Unadjusted | Adjusted | |||
---|---|---|---|---|
Risk factor | OR (95% CI) | P value | OR (95% CI) | P value |
Progression of MOF | ||||
Carotid-femoral PWV | ||||
< 8.1 m/s | 2.57 (0.38–22.76) | 0.34 | 2.50 (0.37–22.71) | 0.37 |
8.1–14.6 m/s | 1.0 (reference) | NA | 1.00 (reference) | NA |
14.6–24.7 m/s | 0.64 (0.03–8.13) | 0.74 | 0.62 (0.03–8.3) | 0.73 |
> 24.7 m/s | 1.13 (0.11–11.26) | 0.92 | 1.08 (0.11–10.97) | 0.94 |
Use of vasopressors | 1.97 (0.40–11.52) | 0.42 | ||
Improvement of CV failure | ||||
Carotid-femoral PWV | ||||
< 8.1 m/s | 2.10 (0.39–12.48) | 0.40 | ||
8.1–14.6 m/s | 1.0 (reference) | NA | ||
14.6–24.7 m/s | 1.0 (0.16–6.19) | 1.0 | ||
> 24.7 m/s | 2.63 (0.46–16.78) | 0.28 |